Vaginal Flora Imbalance Clinical Trial
Official title:
Assessment of Dermal Acceptance, Gynecological and pH Maintenance With Microbiological Analysis of Vaginal Secretion for Cosmetic Product
This is a single-centre, single-blind, non-comparative clinical trial to assess the safety of the investigational product through clinical probability assessment. Thirty-three female participants, aged between 18-45, will be required. Assessment of dermal (dermatological) and gynecological acceptance, in addition to pH measurements and vaginal force collection for microbiological analysis at the beginning and end of the study.
This is a single-centre, single-blind, non-comparative clinical trial to assess the safety of the investigational product through clinical probability assessment. Thirty-three female participants, aged between 18-45, will be required. Assessment of dermal (dermatological) and gynecological acceptance, in addition to pH measurements and vaginal force collection for microbiological analysis at the beginning and end of the study. Participants will remain in the study for a minimum period of 30 days, using the product for the same period according to the flow below: Flow of Visits: Visit 01 (D0) - Participants' consent process after understanding the study; - Initial assessments: safety clinics (dermatologist/gynecologist); - Vaginal pH measurement; - Collection of vaginal secretion; - Dispensing of the usage diary; - Investigational product dispensing. Visit 02 (D30 ±2 days) - Final assessments: clinical safety assessments (dermatologist/gynecologist); - Vaginal pH measurement; - Collection of vaginal secretion; - Collection of the usage diary; - Return of the product; - Subjective questionnaire (self-assessment) to capture possible feelings of discomfort; - Completion of the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03701893 -
Evaluate the Use of a New Probiotic Strain in Couples With Fertility Problems and Dysbiosis.
|
N/A | |
| Completed |
NCT05114031 -
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis
|
N/A | |
| Recruiting |
NCT05640700 -
Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
|
||
| Recruiting |
NCT05850078 -
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)
|
N/A | |
| Completed |
NCT04721938 -
Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment
|
N/A | |
| Recruiting |
NCT05150639 -
Vaginal Microbiome and IVF Pregnancy Outcome
|
||
| Completed |
NCT03843112 -
Modulating the Vaginal Microbiome After Implantation Failure
|
Phase 4 | |
| Recruiting |
NCT05808816 -
"Lactobacillus Crispatus M247, LSIL and Microbiota"
|
Phase 4 | |
| Recruiting |
NCT05573334 -
Vaginal Care System for Menopausal Women With Urinary Tract Infections
|
N/A | |
| Completed |
NCT03734523 -
Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis
|
||
| Completed |
NCT04171947 -
Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment
|
N/A | |
| Not yet recruiting |
NCT04658355 -
Chlorhexidine Gluconate Versus Povidone-iodine
|
N/A | |
| Recruiting |
NCT04202302 -
Vaginal Profile in IVF/ICSI and Impact on Clincal Outcome
|